Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting: 52-Week Data From the Phase 4 ARTISTYK Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s649, 2025. DOI: 10.25251/7j9e8h28. Disponível em: https://skin.dermsquared.com/skin/article/view/3903. Acesso em: 21 apr. 2026.